Page 12 - v11i4
P. 12

International

                                                                         Journal of Bioprinting



                                        REVIEW ARTICLE
                                        Hierarchical 3D-printed scaffolds for

                                        osteochondral regeneration: From biomimetic
                                        design to functional integration



                                        Qi Wang , Wei Zhu , Ruoying Wang , and Xisheng Weng*  id
                                                         id
                                               id
                                                                        id
                                        Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical
                                        Sciences & Peking Union Medical College, 100730 Beijing, China
                                        (This article belongs to the Special Issue: Advances in Bioprinting and Organ-on-a-chip and Applications for
                                        Precision Medicine)

                                        Abstract

                                        Osteochondral defects, characterized by the structural and functional disruption
                                        of articular cartilage and subchondral bone, present significant clinical challenges
                                        due to  the tissue’s limited intrinsic regenerative capacity.  Scaffold-based  tissue
                                        engineering has paved the way for osteochondral defect treatment; however, fully
                                        restoring the complex structure and composition of native osteochondral tissue
                                        remains challenging. Recent advances in three-dimensional (3D) printing have
                                        enabled the fabrication of layered, anisotropic scaffolds designed to biomimetically
                                        recapitulate the native tissue’s zonal properties through precise hierarchical design.
                                        High-resolution  fabrication  techniques  facilitate  the  construction  of  delicate
                                        microarchitectures, while advanced bioprinting methods allow for the incorporation
                                        of bioactive factors and cells into the scaffold matrix. This review emphasizes the
            *Corresponding author:      following four scaffold design paradigms: composite gradients, microarchitectural
            Xisheng Weng                patterning, biochemical gradients, and cellular heterogeneity. Moreover,
            (xshweng@medmail.com.cn)
                                        key  properties  of  multilayered  scaffolds  are  discussed,  including  mechanical
            Citation: Weng X, Wang R, Zhu W,   performance, interfacial strength, and degradation behavior. In addition, several
            Wang Q. Hierarchical 3D-printed   obstacles associated with the in vivo scaffold application are discussed, providing
            scaffolds for osteochondral
            regeneration: From biomimetic   insights to guide future clinical translation in osteochondral defects treatment.
            design to functional integration.
            Int J Bioprint. 2025;11(4):4-31.
            doi: 10.36922/IJB025120100  Keywords:  3D-printed scaffold; Biomaterials; Osteoarthritis; Osteochondral
            Received: March 22, 2025    regeneration; Regenerative medicine; Tissue engineering
            Revised: April 16, 2025
            Accepted: April 28, 2025
            Published online: April 28, 2025
            Copyright: © 2025 Author(s).   1. Introduction
            This is an Open Access article
            distributed under the terms of the   Osteochondral defect, caused by injury or various forms of arthritis including
            Creative Commons Attribution   osteoarthritis (OA), imposes a growing global health burden.  Over 500 million
                                                                                            1,2
            License, permitting distribution,                                3
            and reproduction in any medium,   individuals worldwide are suffering from OA,  making it the seventh leading cause of
                                               4
            provided the original work is   disability.  Notably, early-onset OA (diagnosed before the age of 55) accounts for over
            properly cited.             50% of new cases,  indicating a growing trend of osteochondral injuries occurring in
                                                       5
            Publisher’s Note: AccScience   younger populations. Unfortunately, osteochondral tissue has limited self-healing
            Publishing remains neutral with   capability due to cartilage avascularity.  Current therapeutic approaches include the
                                                                        6
            regard to jurisdictional claims in
            published maps and institutional   following: (1) palliative treatment, such as topical or oral administration of non-steroidal
            affiliations.               anti-inflammatory drugs (NSAIDs), corticosteroid intra-articular injections, or physical

            Volume 11 Issue 4 (2025)                        4                             doi: 10.36922/IJB025120100
   7   8   9   10   11   12   13   14   15   16   17